Rabies
📧 Sign up to get email alerts when something new happens for Rabies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of Verorab in a one-week intradermal post-exposure prophylaxis regimen for rabies.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults [Phase 3]
Phase 3 trial comparing Purified Vero Rabies Vaccine with two reference rabies vaccines in a simulated post-exposure regimen in adults; resu…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects [Phase 2, Phase 3]
Phase II/III trial assessing the safety and effectiveness of HRIG with active rabies vaccine in healthy subjects has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies [Phase 3]
A Phase 3 post-marketing study evaluating KamRAB given as a single dose with active rabies vaccine in children exposed to rabies has complet…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. [Phase 4]
A Phase 4 clinical trial evaluating the effect of antimalarial drugs on rabies vaccine for post-exposure prophylaxis has completed, with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Immunogenicity and Safety of a Purified Vero Rabies Vaccine [Phase 2]
Phase 2 trial update on immunogenicity and safety of a purified Vero Rabies vaccine.
-
FDA approval · 2020-12-21FDA Approved: EBANGA — Original Application (Emergent Manufacturing Operations Baltimore, LLC)
FDA approves EBANGA (ansuvimab) from Emergent Manufacturing Operations Baltimore, LLC through an original biologics license application for …
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Safety of Rabivax-S for Pre-exposure Prophylaxis [Phase 4]
A Phase 4 trial update assessing the safety of Rabivax-S for pre-exposure prophylaxis, completed.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine . [Phase 3]
Phase 3 trial update reporting immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine; study completed.
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Simplifying the Rabies Pre-exposure Vaccination [Phase 3]
Phase 3 trial update on simplifying the rabies pre-exposure vaccination regimen.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating safety, pharmacodynamics, and pharmacokinetics of a single dose of SYN023 with licensed rabies va…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults [Phase 1]
Phase 1 study assessing the safety and tolerability of CV8102 alone and in combination with a rabies virus vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response [NA]
A completed clinical study evaluating the dosing of human rabies immunoglobulin (HRIG) and its effect on the development of an active immune…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG [Phase 4]
A Phase 4 clinical trial evaluated the immunogenicity and safety of a chromatographically purified Vero cell rabies vaccine given with an in…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins [NA]
This clinical trial evaluated the immunogenicity of a reduced four-dose rabies vaccine schedule with rabies immunoglobulin.
-
CLINICAL_TRIALS withdrawal · 2018-02-26Clinical Trial Update: A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children [Phase 4]
A Phase 4 trial evaluating two different rabies vaccine post-exposure regimens in Chinese children has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use [Phase 2]
Phase 2 trial comparing purified Vero Rabies Vaccine, serum-free, with human diploid cell vaccine for pre-exposure use in rabies.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen [Phase 2]
Two vaccines were compared in a Phase 2 pre-exposure rabies prophylaxis trial and the study has completed. The trial was sponsored by Sanofi…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children [Phase 4]
A Phase 4 clinical trial update evaluating the durability of immune responses after post-exposure prophylaxis with Rabipur rabies vaccine in…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age [Phase 3]
Phase 3 trial assesses safety and immunogenicity of two intradermal rabies vaccine regimens administered with or without human rabies immuno…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients [NA]
A completed clinical trial assessed whether rabies immunoglobulin influences the immunogenicity of post-exposure rabies vaccination in obese…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen [Phase 2]
Phase 2 results evaluate the efficacy and safety of a PIKA adjuvant-containing rabies vaccine given on an accelerated regimen.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly [NA]
This clinical trial update reports a completed safety study of the INDIRAB rabies vaccine given post-exposure as five intramuscular doses of…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects. [Phase 2]
Phase 2 trial assessing safety and immunogenicity of recombinant human rabies immunoglobulin (rhRIG) in combination with rabies vaccine in h…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans [Phase 3]
Phase 3 trial assessing safety and immunogenicity of a freeze-dried rabies vaccine produced in MRC-5 cells in Chinese participants has compl…